Abstract:We read with great interest the recent article by Caramés et al, who demonstrated that glucosamine can activate autophagy in human chondrocytes and in mouse knee joints by inhibiting the Akt/FoxO/mammalian target of rapamycin pathway (1). Importantly, the authors proved that intraperitoneal and oral administration of glucosamine induced similar levels of autophagy in the cartilage, thus providing a convenient method for inducing autophagy in vivo in the future. Similarly, another study also demonstrated the inductive effect of glucosamine on autophagy in HeLa and COS-7 cells (2). Glucosamine has been shown to play antiinflammatory, anticatabolic, and antiapoptotic roles in the chondrocyte (3, 4), and in the future autophagy might be identified as a mechanism mediating these effects. However, as mentioned in reports suggesting double roles of autophagy in disease (5), the negative effect of “autophagic cell death” on chondrocytes may need to be elucidated. After treating normal chondrocytes from SD rats with 100 mM glucosamine for 24 hours, we observed that the cytoplasm of cells in monolayer culture was filled with numerous vacuoles (Figure 1). When the incubation time was extended, an increasing number of chondrocytes died, which indicated that glucosamine at high concentrations may lead to autophagic cell death. Although we could not determine whether the cells died due to autophagy, the results suggested that high-dose glucosamine may have a negative effect on cell viability. Photomicrographs obtained by phase-contrast microscopy, showing the morphology of chondrocytes treated with 100 mM glucosamine for 24 hours, at A, lower magnification (100×) and B, higher magnification (400×). In accordance with our observations, De Mattei et al showed that glucosamine at doses of 6.5 mg/ml (∼30 mM) and 25 mg/ml (∼116 mM) decreased cell viability in bovine cartilage explants by 28% and >90%, respectively (6). Moreover, ultrastructural analysis showed that the cells in which death was induced by glucosamine exhibited obvious vacuoles in the cytoplasm (6). In addition, Walsh and colleagues reported that after 4 days and 7 days of exposure to glucosamine at a dose of 4.5 mg/ml (∼20 mM), the DNA content of annulus fibrosus cells was reduced by 75% and 89%, respectively (7). Therefore, it may be imperative to place the emphasis on the concentration when treating chondrocytes with glucosamine. In summary, although an increasing number of studies have suggested that there may be a role for autophagy in the treatment of arthritis, further studies, especially in the human system, are still needed to rule out any negative effects. Supported by the Natural Science Foundation of China (grant 81372002) and the “Technology Innovation Action Plan” Key Project of the Shanghai Science and Technology Commission (grant 12411951300).

Autophagy Protects Chondrocytes from Glucocorticoids-Induced Apoptosis Via ROS/Akt/FOXO3 Signaling.

Glucocorticoid caused lactic acid accumulation and damage in human chondrocytes via ROS-mediated inhibition of Monocarboxylate Transporter 4

Glucocorticoids Induce Apoptosis and Matrix Metalloproteinase-13 Expression in Chondrocytes Through the NOX4/ROS/p38 MAPK Pathway.

PPAR γ activation in chondrocytes alleviates glucocorticoid-induced oxidative stress, mitochondrial impairment, and pyroptosis via autophagic flow enhancement

Glucocorticoid promotes osteoblast viability by activating autophagy via the SGK1/FOXO3a signal pathway

Autophagy Protects Meniscal Cells from Glucocorticoids-Induced Apoptosis Via Inositol Trisphosphate Receptor Signaling.

Autophagy Relieves the Function Inhibition and Apoptosis‑promoting Effects on Osteoblast Induced by Glucocorticoid.

Quercetin Mediates TSC2-RHEB-mTOR Pathway to Regulate Chondrocytes Autophagy in Knee Osteoarthritis.

Glucocorticoids Enhanced Osteoclast Autophagy Through the PI3K/Akt/mTOR Signaling Pathway

Dexamethasone-induced production of reactive oxygen species promotes apoptosis via endoplasmic reticulum stress and autophagy in MC3T3-E1 cells

Low‐dose dexamethasone promotes osteoblast viability by activating autophagy via the SGK1/FOXO3a signaling pathway

Long term usage of dexamethasone accelerating the initiation of osteoarthritis via enhancing the extracellular matrix calcification and apoptosis of chondrocytes

Long term usage of dexamethasone accelerating accelerates the initiation of osteoarthritis via enhancing chondrocyte apoptosis and the extracellular matrix calcification and apoptosis of chondrocytes

Glucocorticoid impairs cell-cell communication by autophagy-mediated degradation of connexin 43 in osteocytes

Dexamethasone Induces Osteoblast Apoptosis Through ROS-PI3K/AKT/GSK3β Signaling Pathway.

Glucocorticoids Induces Apoptosis in Chondrocytes Through the Regulation of 11Β-Hydroxysteroid Dehydrogenases (11Β-Hsds)

Continuous infusion of dexamethasone aggravates the damage of cartilage via upregulating p-AKT and impairing articular autophagy in experimental OA model

The Potential Negative Effect of High‐Dose Glucosamine on the Chondrocyte: Comment on the Article by Caramés Et Al

Lactoferrin Inhibits Dexamethasone-Induced Chondrocyte Impairment from Osteoarthritic Cartilage Through Up-Regulation of Extracellular Signal-Regulated Kinase 1/2 and Suppression of FASL, FAS, and Caspase 3

FoxO transcription factors support oxidative stress resistance in human chondrocytes

Glucocorticoids induce osteonecrosis of the femoral head in rats via PI3K/AKT/FOXO1 signaling pathway